Acute Promyelocytic Leukemia — Trials

Acute Promyelocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07597941	Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients	not yet recruiting	Phase 2 / Phase 3	20	The Affiliated People's Hospital of Ningbo UniversityOTHER_GOV	0	Jun 30, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 30, 2026source: clinicaltrials